OZEM Among Its Peers
End-of-day Nov 19, 2026 · 0 ETFs by 5Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.3% | −6.1% | −2.2% | −13.3% | −14.1% | −8.6% | — | — | — | +17.2% |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$205 of every $1,000 in OZEM is Eli
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 20.46% |
| 2 | NVO | Novo Nordisk A/S | 10.82% |
| 3 | 4519.T | Chugai Pharmaceutical | 7.23% |
| 4 | 128940.KS | Hanmi Pharm | 6.93% |
| 5 | PFE | Pfizer | 5.81% |
| 6 | 1093.HK | CSPC Pharmaceutical Group | 4.77% |
| 7 | KLRA | Kailera Therapeutics | 4.57% |
| 8 | 1276.HK | Jiangsu Hengrui Pharmaceuticals | 4.13% |
| 9 | 3692.HK | Hansoh Pharmaceutical Group | 3.77% |
| 10 | VKTX | Viking Therapeutics | 3.72% |
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 20.46% | $2,046.03 | 8,083 | $11.2M |
| 2 | NVONovo Nordisk A/S | Healthcare | 10.82% | $1,081.97 | 150K | $5.9M |
| 3 | 4519.TChugai Pharmaceutical | Healthcare | 7.23% | $722.99 | 87K | $3.9M |
| 4 | 128940.KSHanmi Pharm | Healthcare | 6.93% | $692.62 | 12K | $3.8M |
| 5 | PFEPfizer | Healthcare | 5.81% | $581.46 | 113K | $3.2M |
| 6 | 1093.HKCSPC Pharmaceutical Group | Healthcare | 4.77% | $476.91 | 2.6M | $2.6M |
| 7 | KLRAKailera Therapeutics | Healthcare | 4.57% | $456.76 | 212K | $2.5M |
| 8 | 1276.HKJiangsu Hengrui Pharmaceuticals | Healthcare | 4.13% | $413.17 | 380K | $2.3M |
| 9 | 3692.HKHansoh Pharmaceutical Group | Healthcare | 3.77% | $376.87 | 494K | $2.1M |
| 10 | VKTXViking Therapeutics | Healthcare | 3.72% | $371.63 | 78K | $2.0M |
| 11 | 1672.HKAscletis Pharma | Healthcare | 3.29% | $329.00 | 3.2M | $1.8M |
| 12 | AZNAstraZeneca | Healthcare | 3.28% | $328.09 | 10K | $1.8M |
| 13 | AMGNAmgen | Healthcare | 3.00% | $299.76 | 3,689 | $1.6M |
| 14 | ZEAL.COZealand Pharma A/S | Healthcare | 2.99% | $299.25 | 50K | $1.6M |
| 15 | ROP.SWRoche AG | Healthcare | 2.81% | $281.44 | 3,213 | $1.5M |
OZEM has no close peers in our data yet: […]
No peers with a full year of prices to rank against yet.
| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| OZEM | −0.46 | −0.68 | 23.4% | −22.4% | 0.77 | $59 |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.41 |
| Dec 30, 2024 | Dec 31, 2024 | $0.0531 |